Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 2Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 50Lung Neoplasms 25Neoplasms 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Neoplasm Metastasis 6Colorectal Neoplasms 5Pancreatic Neoplasms 4Mesothelioma, Malignant 3Melanoma 3Colonic Neoplasms 3Carcinoma 3Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Ovarian Neoplasms 2Non-squamous Non-small Cell Lung Cancer 2Neoplasms by Site 2Mesothelioma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Adenocarcinoma of Lung 2Vaccinia 1Uterine Cervical Neoplasms 1Thoracic Neoplasms 1Solitary Fibrous Tumor, Pleural 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Salivary Gland Neoplasms 1Respiratory Tract Neoplasms 1

Interventions

Oxaliplatin 9Leucovorin 8Fluorouracil 8Bevacizumab 6Cetuximab 5Specimen Handling 4fludarabine 3Pemetrexed 3Nivolumab 3Magnetic Resonance Spectroscopy 3Cyclophosphamide 3pembrolizumab 2encorafenib 2dehydroftorafur 2aldesleukin 2Laparoscopy 2Irinotecan 2Immunoglobulin G 2Gemcitabine 2Folfox protocol 2Disulfides 2Conversion to Open Surgery 2Cisplatin 2Celecoxib 2Carboplatin 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1temsirolimus 1sapanisertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Colonic Neoplasms × Pemetrexed × 30 days × Clear all
NCT06607185 2026-05-26

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Eli Lilly and Company

Phase 1 Active not recruiting
750 enrolled
GastrointestinalGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06704724 2026-05-22

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Pfizer

Phase 1 Terminated
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

NCT07594626 2026-05-19

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

Northwestern University

Phase 1/2 Not yet recruiting
72 enrolled
Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡